Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). (Q37098363)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). (English)

1 reference

Europe PubMed Central

18 August 2017

atrial fibrillation

0 references

3

object named as

Stanley Nattel

1 reference

Europe PubMed Central

18 August 2017

9

object named as

Mario Talajic

1 reference

Europe PubMed Central

18 August 2017

Jean-Claude Tardif

4

object named as

Jean-Claude Tardif

1 reference

Europe PubMed Central

18 August 2017

6

object named as

Normand Racine

1 reference

Europe PubMed Central

18 August 2017

author name string

Maryse Palardy

1

1 reference

Europe PubMed Central

18 August 2017

Anique Ducharme

2

1 reference

Europe PubMed Central

18 August 2017

Michel White

5

1 reference

Europe PubMed Central

18 August 2017

Karine Tétreault

7

1 reference

Europe PubMed Central

18 August 2017

Farida Dabouz

8

1 reference

Europe PubMed Central

18 August 2017

Denis Roy

10

1 reference

Europe PubMed Central

18 August 2017

CTAF Investigators

11

1 reference

Europe PubMed Central

18 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

18 August 2017

The Canadian Journal of Cardiology

1 reference

Europe PubMed Central

18 August 2017

24

1 reference

Europe PubMed Central

18 August 2017

9

1 reference

Europe PubMed Central

18 August 2017

709-713

1 reference

Europe PubMed Central

18 August 2017

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Electrical, contractile and structural remodeling during atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

The tachycardia-induced dog model of atrial fibrillation. clinical relevance and comparison with other models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

29 September 2017

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

27 June 2018

Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Incidence of and risk factors for atrial fibrillation in older adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Effect of atrial fibrillation on atrial refractoriness in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643177

3 September 2018

Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrical remodeling in atrial fibrillation. Time course and mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ionic mechanisms of electrical remodeling in human atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0828-282X(08)70670-6

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37098363&oldid=1754314832"